FDA Inspection
Armstrong Pharmaceuticals, Inc.Armstrong Pharmaceuticals, Inc. – FDA Inspection, Apr 3, 2014
Record Details
This FDA Inspection record concerns Armstrong Pharmaceuticals, Inc., with an inspection on April 3, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- April 3, 2014
- Product Type
- Drugs
View Company Profile
ID · 33b58beb-7c35-4896-b802-8bef38d5f0ee
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 872285
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Armstrong Pharmaceuticals, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2026 | VAI | New England District Office | Drug Quality Assurance |
| July 19, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 14, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 5, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Armstrong Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.